110 related articles for article (PubMed ID: 5140007)
1. Irreversible enzyme inhibitors. 186. Irreversible inhibitors of the C'la component of complement derived from m-(phenoxypropoxy)benzamidine by bridging to a terminal sulfonyl fluoride.
Baker BR; Cory M
J Med Chem; 1971 Sep; 14(9):805-8. PubMed ID: 5140007
[No Abstract] [Full Text] [Related]
2. Irreversible enzyme inhibitors. 180. Irreversible inhibitors of the C'la component of complement derived from m-(phenoxypropoxy)benzamidine and phenoxyacetamide.
Baker BR; Cory M
J Med Chem; 1971 Feb; 14(2):119-25. PubMed ID: 5544395
[No Abstract] [Full Text] [Related]
3. Irreversible enzyme inhibitors. 185. Active-site-directed irreversible inhibitors of guanine deaminase derived from 9-phenylguanine bearing a terminal sulfonyl fluoride. 2.
Baker BR; Siebenneick HU
J Med Chem; 1971 Sep; 14(9):802-5. PubMed ID: 5168672
[No Abstract] [Full Text] [Related]
4. Inhibition of guinea-pig complement by derivatives of benzamidine. I. Effect of p-nitrophenylureido derivative of m-(m-phenoxypropoxy)benzamidine on guinea-pig complement component haemolytic activity.
Glovsky MM; Cory M; Alenty A
Immunology; 1974 Apr; 26(4):819-29. PubMed ID: 4136824
[TBL] [Abstract][Full Text] [Related]
5. Irreversible enzyme inhibitors. 183. Proteolytic enzymes. 18. Inhibitors of guinea pig complement derived by quaternization of phenylalkylpyridines with -bromomethylbenzenesulfonyl fluorides.
Baker BR; Doll MH
J Med Chem; 1971 Sep; 14(9):793-9. PubMed ID: 5168671
[No Abstract] [Full Text] [Related]
6. Irreversible enzyme inhibitors. CLXIV. Proteolytic enzymes. XIV. Inhibition of guinea pig complement by meta-substituted benzamidines.
Baker BR; Cory M
J Med Chem; 1969 Nov; 12(6):1049-52. PubMed ID: 5389146
[No Abstract] [Full Text] [Related]
7. Irreversible enzyme inhibitors. CXLIV. Proteolytic enzymes. VII. Additonal active-site-directed irreversible inhibitors of trypsin derived from m- and p-(phenoxyalkoxy)benzamidines with a terminal sulfonyl fluoride.
Baker BR; Erickson EH
J Med Chem; 1969 Jan; 12(1):112-7. PubMed ID: 5763005
[No Abstract] [Full Text] [Related]
8. Inhibition of the haemolytic complement activity by derivatives of benzamidine.
Hauptmann J; Markwardt F
Biochem Pharmacol; 1977 Feb; 26(4):325-9. PubMed ID: 849323
[No Abstract] [Full Text] [Related]
9. Irreversible enzyme inhibitors. CXV. Proteolytic enzymes. V. Active-site-directed irreversible inhibitors of trypsin derived from p-(phenoxyalkoxy) benzamidines with a terminal sulfonyl fluoride.
Baker BR; Erickson EH
J Med Chem; 1968 Mar; 11(2):245-9. PubMed ID: 5654210
[No Abstract] [Full Text] [Related]
10. Irreversible enzyme inhibitors. CLXV. Proteolytic enzymes. XV. Inhibition of guinea pig complement by derivatives of m-phenoxypropoxybenzamidine.
Baker BR; Cory M
J Med Chem; 1969 Nov; 12(6):1053-6. PubMed ID: 5389147
[No Abstract] [Full Text] [Related]
11. Comparative inhibition of thrombin, plasmin, trypsin, and complement by benzamidines using substituent constants and regression analysis.
Coats EA
J Med Chem; 1973 Oct; 16(10):1102-6. PubMed ID: 4270699
[No Abstract] [Full Text] [Related]
12. Inactivation of the first component of human complement by m-(o-(2-chloro-5-fluorosulfonylphenylureido)-phenoxybutoxy)benzamidine.
Bing DH; Mernitz JL; Spurlock SE
Biochemistry; 1972 Nov; 11(23):4263-8. PubMed ID: 4673057
[No Abstract] [Full Text] [Related]
13. Catalysis of C'2 fixation by C'la. Reaction kinetics, competitive inhibition by TAMe, and transferase hypothesis of the enzymatic action of C'la on C'2, one of its natural substrates.
Stroud RM; Austen KF; Mayer MM
Immunochemistry; 1965 Sep; 2(3):219-34. PubMed ID: 4956916
[No Abstract] [Full Text] [Related]
14. Irreversible enzyme inhibitors. CXLV. Proteolytic enzymes. 8. Active-site-directed irreversible inhibitors of alpha-chymotrypsin derived from alpha-(2-carboxy-4-chlorophenoxy)acetamide bearing a terminal sulfonyl fluoride.
Baker BR; Hurlbut JA
J Med Chem; 1969 Jan; 12(1):118-22. PubMed ID: 5763006
[No Abstract] [Full Text] [Related]
15. Structure-activity relationships in immunochemistry. 2. Inhibition of complement by benzamidines.
Hansch C; Yoshimoto M
J Med Chem; 1974 Nov; 17(11):1160-7. PubMed ID: 4415920
[No Abstract] [Full Text] [Related]
16. Irreversible enzyme inhibitors. 138. Active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 6-(p-aminomethylphenethyl)-- 2,4-diamino-5-(3,4-dichlorophenyl)pyrimidine with a terminal sulfonyl fluoride.
Baker BR; Vermeulen NM
J Med Chem; 1969 Jan; 12(1):89-91. PubMed ID: 5763048
[No Abstract] [Full Text] [Related]
17. Synthesis and structure-activity study of protease inhibitors. III. Amidinophenols and their benzoyl esters.
Yaegashi T; Nunomura S; Okutome T; Nakayama T; Kurumi M; Sakurai Y; Aoyama T; Fujii S
Chem Pharm Bull (Tokyo); 1984 Nov; 32(11):4466-77. PubMed ID: 6532549
[No Abstract] [Full Text] [Related]
18. Irreversible enzyme inhibitors. CXXXVII. Active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 6-(p-aminomethylphenoxymethyl)-2,4-diamino-5-(3,4-dichlorophenyl)pyrimidine bearing a terminal sulfonyl fluoride.
Baker BR; Vermeulen NM
J Med Chem; 1969 Jan; 12(1):86-8. PubMed ID: 5763047
[No Abstract] [Full Text] [Related]
19. [Synthetic inhibitors of serine proteinases. 4.: Inhibitory effect of substituted anilides of 3- and 4- amidino benzoic acid and amidino-anilides of different benzoic- and benzene sulfonic acids].
Walsmann P; Landmann H; Markwardt F; Stürzebecher J; Vieweg H; Wagner G
Pharmazie; 1974 Jun; 29(6):413-5. PubMed ID: 4277284
[No Abstract] [Full Text] [Related]
20. Synthesis and structure-activity study of protease inhibitors. IV. Amidinonaphthols and related acyl derivatives.
Aoyama T; Okutome T; Nakayama T; Yaegashi T; Matsui R; Nunomura S; Kurumi M; Sakurai Y; Fujii S
Chem Pharm Bull (Tokyo); 1985 Apr; 33(4):1458-71. PubMed ID: 4042222
[No Abstract] [Full Text] [Related]
[Next] [New Search]
